Ben Suen

Ben has worked in both Melbourne and London on cross-border M&A deals across a number of sectors including healthcare, tech and infrastructure. He regularly advises private equity houses and other financial sponsor clients on all types of leveraged M&A, co-investments, disposals, restructurings and portfolio company issues. Ben has been recognised as a Rising Star by The Legal 500 for high-value private equity transactions.

Ben has also undertaken a secondment to Centerbridge Partners as interim European General Counsel. Prior to joining Linklaters, Ben was an associate at a top tier Anglo-Australian law firm.

Work highlights

• iCON Infrastructure on its acquisition of Alliance Medical Group from Life Healthcare Group
• Carlyle on its acquisition of Anthesis, a leading global pure-play sustainability advisory and solutions firm 
• Canadian Pension Plan Investment Board on its disposal of its 50% stake in Arqiva to Digital 9 Infrastructure
• Apax Partners on
  • its disposal of Unilabs to AP Moller - the largest European Healthcare PE exit in 2021
  • the acquisition (in 2016) and then sale (in 2020) of Neuraxpharm, a leading European pharmaceutical company, to funds advised by Permira
• HgCapital on 
  • its acquisitions of Combell Group and TransIP to form Team.Blue (in 2019) and subsequent recapitalisation transaction (in 2022)
  • its acquisition alongside TA Associates of The Access Group
• Oakley Capital on its disposal of Facile.it and reinvestment alongside EQT (in 2018) and further reinvestment alongside Silver Lake (in 2022)

Ben holds Bachelor of Laws and Bachelor of Commerce (major in Economics) degrees from Monash University, Australia. Ben also holds a Graduate Diploma of Legal Practice (Australia).

Ben is admitted as a lawyer to the Supreme Court of Victoria and the Federal Court of Australia and England and Wales.